HYI
Basic information
Region (hg38): 1:43450989-43453989
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HYI gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 14 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 2 | |||||
Total | 0 | 0 | 16 | 4 | 2 |
Variants in HYI
This is a list of pathogenic ClinVar variants found in the HYI region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-43451250-C-T | Likely benign (May 18, 2018) | |||
1-43451261-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
1-43451268-A-C | Likely benign (Aug 31, 2017) | |||
1-43451281-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
1-43451427-C-G | Benign (May 18, 2018) | |||
1-43451539-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
1-43451672-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
1-43451813-G-A | Likely benign (Feb 01, 2024) | |||
1-43451930-C-T | Likely benign (Aug 08, 2017) | |||
1-43452196-CT-C | Developmental and epileptic encephalopathy, 18 | Uncertain significance (Sep 03, 2021) | ||
1-43452222-C-G | not specified | Uncertain significance (Jun 17, 2024) | ||
1-43452224-G-C | not specified | Uncertain significance (Jun 23, 2021) | ||
1-43452257-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
1-43452278-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
1-43452338-G-C | not specified | Uncertain significance (Oct 25, 2023) | ||
1-43453102-C-T | Developmental and epileptic encephalopathy, 18 | Uncertain significance (Dec 31, 2021) | ||
1-43453395-C-T | Likely benign (Aug 24, 2017) | |||
1-43453434-T-C | not specified | Uncertain significance (Dec 17, 2021) | ||
1-43453438-G-C | not specified | Uncertain significance (Oct 05, 2021) | ||
1-43453447-C-T | not specified | Uncertain significance (Jul 26, 2022) | ||
1-43453627-C-T | not specified | Benign (May 04, 2022) | ||
1-43453676-G-C | not specified | Uncertain significance (Jan 05, 2022) | ||
1-43453697-C-G | not specified | Uncertain significance (Jul 06, 2021) | ||
1-43453701-G-A | Likely benign (Aug 01, 2024) | |||
1-43453702-C-T | not specified | Uncertain significance (May 11, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HYI | protein_coding | protein_coding | ENST00000372425 | 8 | 2837 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.24e-14 | 0.00458 | 125678 | 0 | 70 | 125748 | 0.000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.905 | 167 | 137 | 1.22 | 0.00000748 | 1688 |
Missense in Polyphen | 65 | 54.596 | 1.1906 | 695 | ||
Synonymous | -1.40 | 67 | 53.9 | 1.24 | 0.00000283 | 550 |
Loss of Function | -0.774 | 19 | 15.7 | 1.21 | 9.12e-7 | 158 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000384 | 0.000383 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.00131 | 0.00131 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000238 | 0.000237 |
Middle Eastern | 0.00131 | 0.00131 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the reversible isomerization between hydroxypyruvate and 2-hydroxy-3-oxopropanoate (also termed tartronate semialdehyde). {ECO:0000250}.;
- Pathway
- Glyoxylate and dicarboxylate metabolism - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.934
- rvis_EVS
- 0.84
- rvis_percentile_EVS
- 88.3
Haploinsufficiency Scores
- pHI
- 0.157
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.380
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.520
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hyi
- Phenotype
Gene ontology
- Biological process
- biological_process
- Cellular component
- cellular_component
- Molecular function
- molecular_function;protein binding;hydroxypyruvate isomerase activity;racemase and epimerase activity, acting on carbohydrates and derivatives